Sleep-disordered breathing, particularly central sleep apnea, is highly prevalent in HFNEF and is associated with impaired cardiopulmonary function.
Supports SDB evaluation in HFNEF; leaves open whether CSA-targeted therapy improves outcomes.
There is a high prevalence of SDB in HFNEF. In parallel to SHF, CSA patients in particular are characterized by a more impaired cardiopulmonary function. Whether SDB is of prognostic relevance in HFNEF needs to be determined.
No takes yet. Share an insight, caveat, or question.
Bitter et al. (2009) studied this question.